In the evolving landscape of inclusive beauty, Croda’s latest clinical data on Ameyezing™ 4.0 offers formulators a powerful tool to address one of the most persistent concerns in Indian-heritage consumers: periorbital hyperpigmentation.

Developed by Croda Beauty Actives , Ameyezing™ 4.0 is a bioconcealer designed to restore brightness and vitality to the under-eye area. Its key active—Zingiber Zerumbet Extract in Butylene Glycol—targets puffiness, vascular dark circles, and melanin-based pigmentation.

Previously validated on Caucasian and Chinese panels, the ingredient has now been clinically tested on Indian-heritage women, 50% of whom experience moderate to severe dark circles.

Clinical Highlights: Indian-Heritage Panel

– Application Protocol: 1.5% in serum (twice daily) + weekly eye pad use 

– Melanin Index Reduction:  Average: –15.9%   & Maximum: –83% after 56 days (p < 0.01) 

– Visible Results:  100% of participants reported improvement; Excellent tolerance across all skin types

These results underscore the ingredient’s efficacy in melanin-rich skin, where dark circles are often multifactorial—driven by genetics, vascular visibility, and pigment accumulation.

Ameyezing™ 4.0 is COSMOS-approved, produced via an eco-designed process, and backed by transparent ethical sourcing. Ameyezing 4.0™ is based on zerumbone obtained from the supercritical CO2 extraction of organic Zingiber zerumbet (fully transparent supply). For formulators seeking to align with clean beauty standards, it checks all the boxes—efficacy, safety, sustainability, and inclusivity.

Formulation Opportunities : Whether you’re developing: Targeted eye serums, Bioconcealer hybrids, Hydrogel eye patches or Ayurveda-inspired brightening kits Ameyezing™ 4.0 offers a clinically validated active that resonates with Indian consumers and global markets alike.

https://www.crodabeauty.com/en-gb/products/product/5785-ameyezing_1_4.0